Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04836156
Status:
RECRUITING
Last Update Posted:
2022-04-06
First Post:
2021-03-28
Brief Title:
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 HER2 Negative Early Breast Cancer Patients
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
PekingUPH10B004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None